94 related articles for article (PubMed ID: 28464601)
21. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
22. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
[TBL] [Abstract][Full Text] [Related]
23. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.
Liu N; Furukawa T; Kobari M; Tsao MS
Am J Pathol; 1998 Jul; 153(1):263-9. PubMed ID: 9665487
[TBL] [Abstract][Full Text] [Related]
24. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
25. [Expression of CD44 and isoforms v4, v5, v6, v7, v10--new prognostic parameters in ductal pancreatic carcinoma?].
Böttger T; Maschek H; Gottwald W; Lobo M; Brenner W; Junginger T
Chirurg; 1998 Oct; 69(10):1089-92. PubMed ID: 9833191
[TBL] [Abstract][Full Text] [Related]
26. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
27. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
28. Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma.
Destro Rodrigues MF; Sedassari BT; Esteves CM; de Andrade NP; Altemani A; de Sousa SC; Nunes FD
J Oral Pathol Med; 2017 Feb; 46(2):112-120. PubMed ID: 27131799
[TBL] [Abstract][Full Text] [Related]
29. Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.
Byers JT; Paniccia A; Kaplan J; Koenig M; Kahn N; Wilson L; Chen L; Schulick RD; Edil BH; Zhu Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1574-9. PubMed ID: 25519928
[TBL] [Abstract][Full Text] [Related]
30. [Clinical implication of BRSK2 expression in pancreatic ductal adenocarcinoma].
Niu GM; Ji Y; Jin DY; Hou J; Lou WH
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1084-8. PubMed ID: 20646422
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
32. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
33. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
37. Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.
Hinton J; Callan R; Bodine C; Glasgow W; Brower S; Jiang SW; Li J
Expert Rev Mol Diagn; 2013 Jun; 13(5):431-43. PubMed ID: 23782251
[TBL] [Abstract][Full Text] [Related]
38. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
39. Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma.
Skoda J; Hermanova M; Loja T; Nemec P; Neradil J; Karasek P; Veselska R
PLoS One; 2016; 11(7):e0159255. PubMed ID: 27414409
[TBL] [Abstract][Full Text] [Related]
40. Expression of ICAM-1, E-cadherin, periostin and midkine in metastases of pancreatic ductal adenocarcinomas.
Grupp K; Melling N; Bogoevska V; Reeh M; Uzunoglu FG; El Gammal AT; Nentwich MF; Izbicki JR; Bogoevski D
Exp Mol Pathol; 2018 Apr; 104(2):109-113. PubMed ID: 29355490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
